Home » Genomic Health Launches Oncotype Liquid Biopsy Test
Genomic Health Launches Oncotype Liquid Biopsy Test
June 14, 2016
Genomic Health has introduced the Oncotype SEQ Liquid Select, its first liquid biopsy test, the Redwood City, Calif.-based company announced Tuesday.
The next-generation sequencing-based assay assesses 17 genes to identify genomic markers linked to sensitivity or resistance to some FDA-approved therapies to improve treatment selection.
"This blood-based test will provide oncologists with important genomic information reported in a manner that will allow efficient interpretation and identification of potential treatment options,” said Phil Febbo, Genomic Health’s chief medical officer. — Anisa Jibrell
Upcoming Events
-
21Oct